Advanced search
Publication Cover
Clinical Ophthalmology Volume 15, 2021 - Issue
Submit an article Journal homepage
118
Views
2
CrossRef citations to date
0
Altmetric
Original Research

Aflibercept versus Ranibizumab as a Second Line Therapy After Bevacizumab for Diabetic Macular Edema

Nasser G Alsaedi1 King Khaled Eye Specialist Hospital, Riyadh, Saudi Arabia;2 King Abdullah Medical City, Makkah, Saudi ArabiaORCID Iconhttps://orcid.org/0000-0001-6299-6040
ORCID Icon,
Ruba M Alselaimy3 College of Medicine, King Saud University, Riyadh, Saudi Arabia
,
Abdulaziz A Alshamrani1 King Khaled Eye Specialist Hospital, Riyadh, Saudi ArabiaORCID Iconhttps://orcid.org/0000-0002-0392-0123
ORCID Icon,
Muhammed AlAjmi4 Albahar Eye Centre, Kuwait City, Kuwait
,
Rajiv Khandekar1 King Khaled Eye Specialist Hospital, Riyadh, Saudi ArabiaORCID Iconhttps://orcid.org/0000-0002-3925-1005
ORCID Icon,
Hassan Al-Dhibi1 King Khaled Eye Specialist Hospital, Riyadh, Saudi Arabia
&
Abdulelah A Al-Abdullah1 King Khaled Eye Specialist Hospital, Riyadh, Saudi ArabiaCorrespondence[email protected]
 show all
Pages 2975-2980 | Published online: 13 Jul 2021

Citations (2)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Moein Ebrahimi, Maryam Balibegloo & Nima Rezaei. (2022) Monoclonal antibodies in diabetic retinopathy. Expert Review of Clinical Immunology 18:2, pages 163-178.
Read now

Articles from other publishers (1)

Mustafa Ataş, Cemal Ozsaygılı, Nurettin Bayram & Sefa Unal. (2022) Retrospective analysis of the efficacy of early switching from bevacizumab to aflibercept or ranibizumab in diabetic macular edema. European Journal of Ophthalmology 33:2, pages 1132-1139.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.